Persistent THC Tolerance in Primates Was Different From a Baseline Attention Deficit

Primates exposed to THC during adolescence were less sensitive to later THC challenges approximately a year after chronic dosing ended. Their baseline attention performance did not show the same group differences. Persistent tolerance and persistent sober impairment are different propositions.

A small longitudinal animal experiment

Twelve squirrel monkeys received vehicle, low-dose THC or high-dose THC during adolescence, four per group. Chronic treatment lasted six months. As adults after an extended interval, they learned a touchscreen vigilance task and received acute THC by oral and intramuscular routes.

The challenge revealed the difference

Groups reached comparable stable task performance before the acute challenges. Larger THC doses were needed to disrupt vigilance in animals with prior chronic THC exposure. Both administration routes showed dose-related effects, although potency and onset differed.

What the experiment did not resolve

The study focused on attention, not a complete cognitive battery. The small sample and unequal sex distribution limited precision, particularly for sex comparisons. Repeated adult challenges also complicate extending this design to many further tasks, because new exposure could add new tolerance.

Do not equate persistence with a proven mechanism

Lasting neural changes were discussed as possible explanations, but this experiment did not establish an irreversible mechanism. Nor did it show that adolescent cannabis exposure improves adult functioning. It identified altered sensitivity to a later drug challenge in an animal model. The distinction between baseline performance and challenge response must be retained before applying the result to human development, treatment or an individual forensic assessment.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Razavi Y; Kohut SJ; Bergman J; Kangas BD. Chronic Δ9-tetrahydrocannabinol exposure during adolescence is associated with persistent behavioural tolerance in adult nonhuman primates. British journal of pharmacology (2025). DOI: 10.1111/bph.70179.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

Adding CBD was associated with less first-day vomiting in a small adolescent-primate experiment, but did not prevent the measured THC-related learning disruption. Improvement in one adverse outcome should not be presented as general protection. Three small treatment groups Twelve male squirrel monkeys received vehicle, THC alone or THC with CBD,…

Spread the love

Read Article: Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

A cannabinoid-receptor mutation associated with altered tolerance in other experiments did not delay THC tolerance in mice with cisplatin-related neuropathy. The result shows why a mechanism demonstrated in one pain model may not transfer to another. A chronic pain model with two sexes Researchers studied wild-type mice and animals carrying…

Spread the love

Read Article: A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Behavior after cannabinoid cessation differed with the compound, dose and observation time in a mouse study. An early negative assessment could miss later changes, while a strong response to a synthetic agonist should not be relabeled as a THC result. Continuous observation added information Researchers compared repeated THC with AM2389,…

Spread the love

Read Article: Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us